Sodium Chloride Hypertonicity Ointment
NDC Package 73581-708-35

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

Sodium Chloride Hypertonicity (sodium chloride) ointment is a medication used to treat dryness inside the nose (nasal passages). This formulation utilizes a ointment delivery system. Marketed by Yyba Corp, this product is identified by NDC 73581-708 and is authorized under FDA application M018.

Identification & Billing

NDC Package Code
73581-708-35
Package Description
1 TUBE in 1 CARTON / 3.5 mL in 1 TUBE
Product Code
11-Digit Billing Format
73581070835
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Sodium Chloride Hypertonicity
Non-Proprietary Name
Sodium Chloride
Substance Name
Sodium Chloride
Dosage Form
Ointment - A semisolid3 dosage form, usually containing <20% water and volatiles5 and >50% hydrocarbons, waxes, or polyols as the vehicle. This dosage form is generally for external application to the skin or mucous membranes.
Administration Route
Ophthalmic - Administration to the external eye.
Active Ingredient(s)
Usage Information
This product is used to treat dryness inside the nose (nasal passages). It helps add moisture inside the nose to dissolve and soften thick or crusty mucus. In babies and young children with stuffy noses who cannot blow their noses, using this product helps to make the mucus easier to remove with a nasal bulb syringe. This helps relieve stuffiness and makes breathing easier. This product contains a purified gentle salt solution (also called saline or sodium chloride solution). It does not contain any medication.

Regulatory & Marketing

Labeler Name
Yyba Corp
Product Type
Human Otc Drug
FDA Application #
M018
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
08-12-2024
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 73581-708-35 identifies a specific commercial package of 1 tube in 1 carton / 3.5 ml in 1 tube of Sodium Chloride Hypertonicity, a human over the counter drug labeled by Yyba Corp. This ointment is formulated for ophthalmic use and contains sodium chloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Yyba Corp on August 12, 2024. The current certification is valid through December 31, 2027.

What are the primary indications for this medication?

This product is used to treat dryness inside the nose (nasal passages). It helps add moisture inside the nose to dissolve and soften thick or crusty mucus. In babies and young children with stuffy noses who cannot blow their noses, using this product helps to make the mucus easier to remove with a nasal bulb syringe. This helps relieve stuffiness and makes breathing easier. This product contains a purified gentle salt solution (also called saline or sodium chloride solution). It does not contain any medication.

How is this Yyba Corp product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 73581070835. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
73581-708-35
11-Digit CMS (5-4-2)
73581-0708-35

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.